FDAClass IINovember 17, 2021

Cjc-1295 4mg/ipamorelin 4mg Vial 4mg/4mg Injectable recall: Sterility Concern

CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247

Why was Cjc-1295 4mg/ipamorelin 4mg Vial 4mg/4mg Injectable recalled?

Lack of assurance of sterility

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot: 05242021:73 BUD: 08/22/2021; 08032021:26 BUD: 11/01/2021; 06022021:49 BUD: 08/31/2021; 08122021:97 BUD: 11/10/2021;

Product
CJC-1295 4MG/IPAMORELIN 4MG VIAL 4MG/4MG INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
Recalling firm
Vita Pharmacy, LLC dba Talon Compounding Pharmacy
Quantity
15 vials
Distribution
United States including Washington, D.C. and Puerto Rico
Recall date
November 17, 2021
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls